In silico clinical trials for pediatric orphan diseases

Area of Science:

• Biomedical Engineering
• Computational Biology
• Regenerative Medicine

Background:

• Congenital pseudarthrosis of the tibia (CPT) is a rare pediatric bone disorder with limited therapeutic strategies.
• Small patient populations in pediatric orphan diseases pose challenges for traditional clinical trials.

Purpose of the Study:

• To evaluate the efficacy of bone morphogenetic protein (BMP) treatment for CPT using an in silico clinical trial.
• To explore the potential of computational modeling and machine learning in addressing challenges in rare pediatric diseases.

Main Methods:

• Generation of 200 virtual subjects based on a murine bone regeneration model.
• Simulation of CPT treatment with and without BMP administration.
• Application of machine learning to stratify virtual subjects based on treatment response.

Main Results:

• BMP treatment significantly reduced CPT severity across virtual subjects.
• Treatment efficacy demonstrated high subject-specific variability.
• Machine learning successfully classified subjects into distinct response categories (responders, non-responders, adverse responders, asymptomatic).

Conclusions:

• In silico medicine offers a powerful approach for studying rare pediatric diseases like CPT.
• BMP shows promise for CPT treatment, with potential for personalized therapeutic strategies.
• Computational modeling can aid in understanding disease variability and optimizing treatment for orphan diseases.